GlassScriptPhysician profile
John J Walsh
NPI 1326073719
$1,038.02
in general payments reported to CMS, 2019-2025
18 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.43 · 2020: $55.50 · 2021: $35.42 · 2022: $216 · 2023: $497 · 2024: $23.03 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $173.06 | 2023 | Phasix Mesh |
| Allergan, INC. | $168.55 | 2022 | |
| Baxter Healthcare | $144.79 | 2019-2025 | |
| Heron Therapeutics, INC. | $125.00 | 2023 | Zynrelef |
| Abbvie INC. | $82.04 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Organogenesis INC. | $43.14 | 2023-2024 | Puraply |
| Davol INC. | $41.95 | 2025 | Phasix Mesh |
| Biom'Up France Sas | $33.21 | 2020 | |
| Biocomposites INC | $30.57 | 2023 | Stimulan |
| Kerecis Limited | $30.45 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Convatec INC. | $25.40 | 2022 | |
| Innovation Technologies INC | $22.95 | 2025 | Irrisept |
| Acell, INC. | $22.29 | 2020 | |
| Trice Medical, INC. | $22.06 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.99 | 2023 | Exparel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $19.14 | 2021 | |
| Mallinckrodt Hospital Products INC. | $16.28 | 2021 | |
| Sanara Medtech INC. | $15.15 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.